• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转钴胺素I作为纤维板层型肝癌的“标志物”。

Transcobalamin I as a "marker" for fibrolamellar hepatoma.

作者信息

Wheeler K, Pritchard J, Luck W, Rossiter M

出版信息

Med Pediatr Oncol. 1986;14(4):227-9. doi: 10.1002/mpo.2950140408.

DOI:10.1002/mpo.2950140408
PMID:3018464
Abstract

A 12 year old girl with a localised fibrolamellar hepatoma had a raised serum unsaturated vitamin B12 binding capacity (UBBC) and transcobalamin I (TCI) prior to complete resection and chemotherapy. Regular clinical and radiological follow-up detected no recurrence of her disease, but the UBBC and TCI slowly rose. Local recurrence and pulmonary metastases became detectable 2 1/2 years after diagnosis, 18 months after the UBBC and TCI level became elevated. Measurement of UBBC and TCI can help in the early detection of recurrence long before there is clinical or radiological evidence of recurrent fibrolamellar hepatoma.

摘要

一名患有局限性纤维板层状肝癌的12岁女孩,在完全切除和化疗前血清不饱和维生素B12结合能力(UBBC)和转钴胺素I(TCI)升高。定期的临床和影像学随访未发现疾病复发,但UBBC和TCI缓慢上升。诊断后2年半,即UBBC和TCI水平升高18个月后,发现局部复发和肺转移。在出现纤维板层状肝癌复发的临床或影像学证据之前很久,测量UBBC和TCI有助于早期发现复发。

相似文献

1
Transcobalamin I as a "marker" for fibrolamellar hepatoma.转钴胺素I作为纤维板层型肝癌的“标志物”。
Med Pediatr Oncol. 1986;14(4):227-9. doi: 10.1002/mpo.2950140408.
2
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.维生素B12结合蛋白作为肝细胞癌的肿瘤标志物
Gut. 1978 Dec;19(12):1105-9. doi: 10.1136/gut.19.12.1105.
3
Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.原发性肝癌患者血清酶与血清不饱和维生素B12结合蛋白之间的相关性
Enzyme. 1988;39(3):161-6. doi: 10.1159/000469112.
4
Blood transcobalamin levels in malignant hepatoma.恶性肝癌患者血液中钴胺传递蛋白水平
Tumour Biol. 1991;12(6):353-9. doi: 10.1159/000217736.
5
Transcobalamin-binding capacities in vitamin B12-related diseases.
Am J Clin Pathol. 1981 May;75(5):677-83. doi: 10.1093/ajcp/75.5.677.
6
The transcobalamins in polycythaemia vera.真性红细胞增多症中的转钴胺素
Scand J Haematol. 1977 Nov;19(5):453-62. doi: 10.1111/j.1600-0609.1977.tb01501.x.
7
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.高血清维生素B12结合能力作为肝细胞癌纤维板层样变体的标志物。
Br Med J (Clin Res Ed). 1982 Sep 25;285(6345):840-2. doi: 10.1136/bmj.285.6345.840.
8
Serum vitamin B12 binders in South African blacks with hepatocellular carcinoma.南非黑人肝细胞癌患者的血清维生素B12结合蛋白
Cancer. 1985 Aug 15;56(4):789-92. doi: 10.1002/1097-0142(19850815)56:4<789::aid-cncr2820560415>3.0.co;2-i.
9
A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female.一名日本年轻女性纤维板层状肝细胞癌术后复发伴维生素B12结合能力增加的病例。
Jpn J Clin Oncol. 2004 Jun;34(6):346-51. doi: 10.1093/jjco/hyh050.
10
Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.维生素B₁₂及其结合蛋白在肝细胞癌和慢性肝病中的研究
Scand J Gastroenterol. 2014 Sep;49(9):1096-102. doi: 10.3109/00365521.2014.921325. Epub 2014 Jun 24.

引用本文的文献

1
Evaluation of Serum Vitamin B12 Levels in Patients with Colon and Breast Cancer: A Case-Control Study.结肠癌和乳腺癌患者血清维生素B12水平的评估:一项病例对照研究。
Int J Hematol Oncol Stem Cell Res. 2023 Oct 1;17(4):240-244. doi: 10.18502/ijhoscr.v17i4.13914.
2
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.纤维板层型肝细胞癌:一种罕见但不良的病症。
World J Gastrointest Oncol. 2022 Jun 15;14(6):1103-1114. doi: 10.4251/wjgo.v14.i6.1103.
3
Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.
与固体肿瘤中钴胺素依赖代谢和转钴胺素合成相关的诊断和治疗观点。
Nutrients. 2022 May 14;14(10):2058. doi: 10.3390/nu14102058.
4
Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.转钴胺素1过表达是接受同步放化疗的直肠癌患者的独立不良预后因素。
J Cancer. 2017 May 12;8(8):1330-1337. doi: 10.7150/jca.18274. eCollection 2017.
5
Fibrolamellar hepatocellular carcinoma: current clinical perspectives.纤维板层肝细胞癌:当前的临床观点。
J Hepatocell Carcinoma. 2015 Oct 9;2:151-7. doi: 10.2147/JHC.S75153. eCollection 2015.
6
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.纤维板层型肝细胞癌的基因组图谱:十位患者的全基因组测序
Oncotarget. 2015 Jan 20;6(2):755-70. doi: 10.18632/oncotarget.2712.
7
Fibrolamellar carcinoma: 2012 update.纤维板层癌:2012年更新
Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Epub 2012 Sep 23.